healthcare · NH
Narayana Hrudayalaya
Narayana Hrudayalaya: PE above historical average. NARROW LEADERSHIP regime.
Price
₹2,080.3
Price 2026-07-30
5 day
+6.06%
Short-term move
1 month
+5.51%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹40.7k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Narayana Hrudayalaya (NH) in the healthcare sector?”
Price chart
₹2,073
-4.27% over period
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physio...
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -7.7% over 14 days) — not a reliable pattern.
52-week position
Trading at 99.4% of 52-week high
Technicals
RSI 14
59.8
Trend
uptrend
50 DMA
Above
200 DMA
Above
Key metrics
P/E ratio
50.2
57th pct · 7 quarterly points (limited history)
P/B
9.0
ROE
19.8%
Moderate profitability — 19.8% ROE
Market cap
₹40.7k Cr
Revenue growth
7580.0% YoY
Promoter
67.2%
52-week range
₹1,589 – ₹2,093.3
99.4% of high
RSI (14)
59.8
uptrend
vs 50 DMA
Above
DMA ₹1,956.76
Coverage
100/100
HIGH
Quick Take
Narayana Hrudayalaya: PE above historical average. NARROW LEADERSHIP regime.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
Key Watchpoints
Breaks above ₹2184 (+5%)
Trend reversal confirmation
Breaks below ₹1976 (-5%)
Further downside risk
PE reverts to median of 47.7 (7 quarterly points (limited history))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal
